Affiliation:
1. N.N. Blokhin National Medical Research Center of Oncology
2. N.N. Blokhin National Medical Research Center of Oncology; Russian Medical Academy of Continuous Professional Education
Abstract
Modern nuclear medicine is a rapidly developing field that includes various non-invasive molecular imaging techniques with the ability to examine the whole body.Inflammation is a frequent complication in surgical and traumatological practices, which is a complex, local and general pathological process that occurs in the body in response to injury. Having arisen under the influence of a damaging factor, inflammation is characterized by the development of a dynamic complex of changes. However, the search for inflammation foci of inflammation by traditional diagnostic methods in some cases is difficult even with a detailed clinical picture. In this case, nuclear medicine, which is able to visualize pathological processes, including those with a pathological increase in metabolism, may be the best option for finding the affected area.A wide variety of radiopharmaceutical drugs makes it possible to determine the localization of the inflammatory focus in a short time and with high accuracy and makes nuclear imaging methods a priority for the early diagnosis of pathophysiological reactions.This paper presents a review of domestic and foreign literature on the use of specific and nonspecific radiopharmaceuticals in the diagnosis of inflammation. Own cases is also presented.
Publisher
Non-profit partnership Society of Interventional Oncoradiologists
Reference54 articles.
1. Stephenson TJ. Inflammation. General and systematic pathology. Ed. J.C.E. Elsevier. London: Underwood. 2004;202-20.
2. Elgazzar AH, Dannoon S, Sarikaya I, Farghali M, Junaid TA. Scintigraphic Patterns of Indium-111 Oxine-Labeled White Blood Cell Imaging of Gram-Negative versus Gram-Positive Vertebral Osteomyelitis. Med Princ Pract. 2017;26(5):415-20. DOI: 10.1159/000480083.
3. Kurazhov AP, Zavadovskaya VD, Kilina OYu, et al. The use of 199Tl-chloride and 99mTc-MIBI for the indication and differential diagnosis of tumor and inflammatory processes in the musculoskeletal system. Bulletin of Siberian Medicine. 2012;11(3):120-31. (In Russian). DOI: 10.20538/1682-0363-2012-3-120-131.
4. Kurazhov AP, Zavadovskaya VD, Choinzonov EL, et al. Possibilities of using nonspecific tumoritropic indicators 99mTc-MIBI, 67Ga-citrate and 199Tl-chloride for differential diagnosis of malignant tumors. Siberian Journal of Oncology. 2012;53(5):5-11. (In Russian).
5. Krylov AS, Shiryaev SV, Polyakov VG, et al. Comparative evaluation of the possibility of scintigraphy with 67Ga-citrate and 99mTc-technetrile in malignant mesenchymal soft tissue tumors in children. Medical Radiology and Radiation Safety. 2010;55(3):63-8. (In Russian).